baber/WOPTO huggingface dataset:
Patent NZ-544190-A (NZ)
Title: Partially open sided outdoor animal shelter with air flow control
Inventor: POW THOMAS GEORGE
Filed: 2005-12-14
Abstract: Outdoor animal shelter structures (20) and methods for controlling the temperature of the environment in the structures are disclosed. The structure is at least partially open sided and includes a floor (2) to support the animals, with apertures in the floor allowing animal waste matter to pass into a basement (3). A partially transparent water impervious canopy (22) is supported above the floor. Air flow control means (24) control the ambient airflow impinging on the structure and entering under the canopy, and the airflow leaving the structure. This allows adjustment of the climate that any animal standing on the floor experiences.
Patent NZ-546438-A (NZ)
Title: Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
Inventor: LI REBECCA
IPC: A61K38/18
Filed: 2004-09-10
Abstract: Disclosed is a composition formulated for injectable delivery of at least one osteogenic protein, wherein said composition comprises an osteogenic protein and a calcium phosphate material selected from the group consisting of amorphous apatitic calcium phosphate and poorly crystalline apatitic calcium phosphate, and wherein said composition is in the form of a hardenable paste that hardens into a solid form at 37 degrees Celsius, wherein the osteogenic protein is selected from the group consisting of members of the bone morphogenetic protein (BMP) family.
Patent NZ-551657-A (NZ)
Title: Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
Inventor: PALLI SUBBA REDDY
IPC: A61K31/47
Filed: 2005-05-02
Abstract: Disclosed is a gene expression modulation system comprising a gene expression cassette that is capable of being expressed in a host cell, the gene expression cassette comprising a polynucleotide that encodes a polypeptide comprising: i) a transactivation domain; ii) a DNA-binding domain that recognizes a response element associated with a gene whose expression is to be modulated; and iii) a Group H nuclear receptor ligand binding domain comprising a mutation at a position equivalent to or analogous to amino acid residue 132 of SEQ ID NO: 1.
Patent NZ-553948-A (NZ)
Title: Microwavable vegetable preparation
Inventor: LEIMKUHLER JAMES K
IPC: A23L19/00
Filed: 2005-08-16
Abstract: Disclosed is a method of packaging a fresh vegetable where the package protects the vegetable and serves as a cooking container. The method comprises the steps of providing a vegetable; providing shrinkable plastic film; attaching an opening system to the film, the opening system configured to open the plastic film after the vegetable has been cooked; modifying gas permeability of the film according to the type of the vegetable; sealing the film around the vegetable; and shrinking the film to tightly envelop the vegetable.
Patent NZ-556456-A (NZ)
Title: Methylphenidate derivatives and uses of them
Inventor: BAR-OR DAVID
IPC: A61K31/445
Filed: 2006-01-20
Abstract: Disclosed is the use of methylphenidate derivatives of formula (I), wherein the substituents are disclosed in the specification, for the manufacture of a medicament for treating proliferative disorders or diseases such as cancer, mesangial cell proliferation disorder, fibrotic disorder, skin disorder, an angiogenic disease or a neoplastic disease. Also disclosed is the methylphenidate compound of formula (I) wherein n is 1, OR7 is aryl and R2 is methyl.
Patent NZ-561358-A (NZ)
Title: Alarm device
Inventor: MACKAY ALLAN DAVID
IPC: B60Q9/00
Filed: 2007-09-11
Abstract: An alarm device comprising a switch circuit (28) having one or more switches (29), adapted for mounting on a vehicle's steering wheel; and a control circuit (20) connected to the switch circuit comprising one or more batteries (26), a main switch, a soft-start circuit, a processor (22) and an alarm means (24). The main switch is arranged to turn the alarm device on and off. The soft-start circuit is arranged to prevent excessive current from being drawn by the control circuit when the main switch is turned on. The processor is arranged to activate the alarm means.
Patent NZ-563078-A (NZ)
Title: Method of purifying polypeptides by simulated moving bed chromatography
Inventor: THOMMES JORG
IPC: C07K1/16
Filed: 2003-09-12
Abstract: Disclosed is a simulated moving bed ("SMB") system for separating an immunoreactive compound from at least one immaterial component when both are present in a fluid mixture, wherein the SMB system incorporates a plurality of zones comprising a solid phase which is contacted counter currently by said fluid mixture and wherein said zones comprise: an association zone wherein the immunoreactive compound and at least one immaterial component differentially associate with the solid phase; a first wash zone wherein at least one immaterial component is preferentially disassociated from the solid phase; and an elution zone wherein the immunoreactive compound is preferentially disassociated from the solid phase.
Patent NZ-563644-A (NZ)
Title: A system with a shielded electrical cable with an armour that is exposed when entering an apparatus
Inventor: MCGHEE STEPHEN
IPC: H02G15/068
Filed: 2006-04-28
Abstract: Disclosed is an electrical system for data transmission over an electricity distribution network. The system comprises of an electrical apparatus and a shielded electrical cable (3) connected to the apparatus, the cable having a core, a metallic sheath (35) around the core and surrounding armour (36). The armour is disengaged from around the metallic sheath at a location where the sheath enters the apparatus and is connected to and supported relative to the apparatus by means of a coupling such that a portion of the sheath is exposed between the location and the armour. The coupling comprises a first end arranged to receive the armour and a second end spaced from, but connected to, the first end, which second end being mounted to a part of the apparatus.
Patent NZ-564925-A (NZ)
Title: Adaptor for an air compressor and an air compressor
Inventor: BOSUA CHRISTOPHER JOHN
IPC: F15B21/14
Filed: 2006-06-01
Abstract: An adaptor (10, 50) for an air compressor (11,51). The adaptor includes a manifold (14,52) having an inlet (20,74) adapted to be connected to the air exhaust of at least one air tool device (34) having an air motor connected, in use, to the air compressor. An outlet (12,54) is adapted to be connected, in use, to the air intake of the air compressor, an air inlet (16,70) is open to ambient air and a valve mechanism (33,66) is adapted to, in use, close the air inlet when a first predetermined pressure is reached by the air compressor.
Patent NZ-565867-A (NZ)
Title: Resorbable polyether esters for producing medical implants
Inventor: BUCHHOLZ BERTHOLD
IPC: A61L27/18
Filed: 2006-07-12
Abstract: Disclosed is a block copolymer of the AB or ABA type with A being a polyester block and B being a polyether block, wherein the AB type is represented by formula I: E-(O-D-CO-) n-(O-CH2-CH2-)m-O-F (formula I) wherein the structural unit E-(-O-D-CO-) n- forms the block A, -(O-CH2-CH2-)m- forms the block B, D may be, for each of the n units independently of one another: -(CH(CH3)-)x or -(CH2-)x or -(CH2-O-CH2-CH2-) or -(CH2-CH2-CH2-O-), x is 1, 2, 3, 4 or 5, E and F independently of one another denote H, methyl or ethyl and n and m are statistically averaged and independently of one another denote an integer greater than 1and the B block makes up a proportion of between 0.1 and 4 wt.percent, and wherein the ABA type is represented by the formula II: E(-O-D-CO)n-(O-CH2-CH2-)m-O-(CO-D-O-)n'-E (formula II), wherein the structural units E-(-O-D-CO-) n- and E-(-O-D-CO-) n'- form the blocks A, -(O-CH2-CH2-)m- forms the block B, D may be, for each of the n or n' units independently of one another: -(CH(CH3)-)x or -(CH2-)x or -(CH2-O-CH2-CH2-) or -(CH2-CH2-CH2-O-), x is 1, 2, 3, 4 or 5, E is H, methyl or ethyl and n, n' and m are statistically averaged and independently of one another denote an integer greater than 1, and the B block makes up a proportion of between 0.1 and 4 wt.percent, and for both the AB or ABA type block copolymers, A is synthesised from a mixture of monomer components selected from among a) D- and L-lactide, b) L-lactide and glycolide, c) D,L-lactide and glycolide, d) L-lactide and epsilon-caprolactone, e) L-lactide and dioxanone, f) L-lactide and trimethylene carbonate. Also disclosed is a process to prepare said block copolymer and an implant and the process of preparing said implant comprising the block copolymer and its associated use in the treatment of paediatric conditions.
Patent NZ-568049-A (NZ)
Title: Treatment and prevention of benign pigmented moles (nevi) using artemisinine and the derivatives thereof
Inventor: SIFT CARTER ROSEMARIE
IPC: A61K9/70
Filed: 2006-10-19
Abstract: Disclosed herein is the used of a compound of formula (I), wherein the substituents are as defined in the specification, for the preparation of a locally applicable formulation for the treatment of benign pigment marks or for the prevention of skin cancer. Also disclosed is a plaster with a topical formulation characterized in that the plaster is adapted for use in the treatment of benign pigment marks or in the prevention of skin cancer, comprises an active ingredient of formula (I) and the formulation is essentially free from penetration-enhancing substances.
Patent NZ-571135-A (NZ)
Title: Beta-Galactosidase with transgalactosylating activity
Inventor: TZORTZIS GEORGIOS
IPC: A23L33/00
Filed: 2007-03-27
Abstract: Disclosed is a beta-galactosidase with transgalactosylating activity which has a DNA sequence which a) encodes a protein with an amino acid sequence as given in SEQ. ID. NO: 2, or b) is a degenerative of the DNA sequence of a), said degenerative being from 75% to 95% sequence identity. Also disclosed is the use of the enzyme for producing a mixture of oligosaccharides.
Patent NZ-577763-A (NZ)
Title: Thin condom comprising natural rubber and polyurethane blend
Inventor: HILL DAVID MICHAEL
IPC: A61F6/04
Filed: 2007-12-20
Abstract: Disclosed is a condom comprising a blend of natural rubber and polyurethane. A process for making the natural rubber and polyurethane blended condom is also disclosed.
Patent NZ-579033-A (NZ)
Title: A duct adaptor for an air conditioning diffuser with gravity biased flaps to prevent back flow of air into the duct
Inventor: STERLING MICHAEL WILLIAM
IPC: F24F13/02
Filed: 2009-08-13
Abstract: A duct adaptor (6) for coupling between a diffuser frame assembly (19) and an air conditioning heating duct is disclosed. The duct adaptor (6) has a first wall (20) to couple to the diffuser frame assembly (19) and a second wall (37) which can be located within an end of the duct. A plurality of baffles (40, 42, 44, 46) are mounted within the second wall (37), the baffles having outer peripheral portions and inner peripheral portions. The baffles (40, 42, 44, 46) are biased into a closed position in which they together span the second wall portion. The outer peripheral portions lye adjacent to second wall (37) and the inner peripheral portions are adjacent to one another. When a predetermined rate of air flows from the duct into the second wall (37), the baffles (40, 42, 44, 46) pivotally move to open positions in which the inner peripheral portions move in a direction upstream of the flow of air in the duct.
Patent NZ-582130-A (NZ)
Title: Methods of inducing melanogenesis in a subject
Inventor: KLEING MICHAEL JOHN
IPC: A61K38/22
Filed: 2005-02-11
Abstract: Provided is the use of a functional alpha-MSH analogues with specified sequences in the manufacture of a medicament for treating and/or preventing photodermatoses by inducing melanogenesis in a human subject, wherein the photodermatoses are skin diseases induced or exacerbated by light or ultraviolet light, and whereby the induced melanogenesis is performed by the melanocytes in epidermal tissue of the subject, and wherein the inducing of melanogenesis does not induce homologous desensitization of the melanocortin-1 receptors of the subject, and wherein the medicament is suitable for: (i) administration in order to achieve a level of the alpha-MSH analogue not exceeding 10 ng/ml in the plasma of the subject for a period of at least 24 hours; and (ii) administration such that the effective concentration of the alpha-MSH analogue in the plasma of the subject is maintained for at least 24 hours.
Patent NZ-592648-A (NZ)
Title: A system for producing radiation diffractive material
Inventor: MERRITT MARK D
IPC: B05D5/06
Filed: 2006-10-26
Abstract: The specification relates to a system for producing radiation diffractive material comprising: a substrate for receiving a dispersion of core-shell particles that form an ordered periodic array, the shells being swellable and substantially nonfilm-forming; a matrix delivery device for coating the array with a matrix composition; a radiation source(which may be a radiation source emitting visible light) for illuminating the coated array; a radiation detector(which may be a spectrograph) for measuring the spectrum of radiation diffracted by the coated array prior to curing components in the coated array; a control system for adjusting the wavelength of diffracted radiation based on the measured spectrum of radiation diffracted by the coated array; and a curing system for curing components in the coated array and fixing the relative positions of the particles, wherein the control system correlates the measured spectrum of light diffracted by the coated array with a desired appearance of the cured array and may optionally include a system for removing the cured array from the substrate(which may also alter the diameter of the particles in the array.
Patent NZ-594637-A (NZ)
Title: Combined action filter press
Inventor: TONGIANI STEFANO
IPC: B01D25/12
Filed: 2010-02-10
Abstract: 594637 Disclosed is a filter press (10) for dehydrating slurries by means of pressing. The filter press includes a supporting frame, constituted of at least one longitudinal rail or guide (11) supported at its opposite ends by a fixed headpiece (12) on one side and by a foot (13) on the other side. A movable headpiece (15) is supported by the at least one guide, which comprises threaded cylindrical holes, supported on relative endless screws (19) the ends of which are rotationally mounted on supports integral with the respective guides. A plurality of filtering plates (14), which are enclosed by cloths, is arranged side by side between the fixed headpiece and the movable headpiece. Pneumatic elements or cushions (20) are arranged between the fixed headpiece and a compression plate (21). In use, a slurry is contained within the space between the filter plates and the endless screws are operated by a motor (22) to drive the movable headpiece to compress the plurality of filter plates against the fixed headpiece. During this process the slurry solids are retained within the space between the filter plates and the liquid drains out through the cloths. The pneumatic cushion is then inflated to further press the slurry.
Patent NZ-596490-A (NZ)
Title: Monoclonal antibodies that bind GT468 for the treatment of cancer
Inventor: SAHIN UGUR
IPC: C07K16/30
Filed: 2009-09-16
Abstract: Disclosed are monoclonal antibodies targeting GT486 and hybridoma for the generation of said antibodies. The mAB's disclosed have anti-tumour and anti-proliferative effects and are considered for the use in treatment of cancerous cells that express GT486.
Patent NZ-597998-A (NZ)
Title: Methods for treating cancer with mva
Inventor: DELCAYRE ALAIN
IPC: A61K39/00
Filed: 2007-10-05
Abstract: 597998 Disclosed is a recombinant Modified Vaccinia Ankara virus (MVA) comprising a heterologous nucleotide sequence encoding a polypeptide comprising a HER-2 antigen, wherein the HER-2 antigen comprises the sequence of SEQ ID NO:2 MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVQYlKANSKFIGITELRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDL8VFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSFNNFTVSFWLRVPKVSASHLEIVSAVVGIL.
Patent NZ-600583-A (NZ)
Title: Visfatin therapeutic agents for the treatment of acne and other conditions
Inventor: TENNENBAUM TAMAR
IPC: A61K31/713
Filed: 2010-01-06
Abstract: NZ 600583 Disclosed is a pharmaceutical composition comprising a visfatin antagonist, a pharmaceutically acceptable carrier and a delivery peptide having the amino acid sequence shown in SEQ ID NO: 27, as defined in the complete specification. Also disclosed is the use of said pharmaceutical composition in the manufacture of a medicament for the treatment of a sebum over-production condition in a subject.
Patent NZ-601171-A (NZ)
Title: Genetic engineering of non-human animals for the production of chimeric antibodies
Inventor: SHIZUYA HIROAKI
IPC: C12N15/13
Filed: 2011-03-31
Abstract: Disclosed is a method of producing a mouse cell comprising a genome that comprises a functional polynucleotide sequence that encodes a chimeric immunoglobulin heavy chain that functionally replaces an endogenous immunoglobulin heavy chain locus, wherein said chimeric immunoglobulin heavy chain comprises a human variable domain and a chimeric constant region, said method comprising the steps of: designing a DNA construct in silico, wherein said construct comprises one or more unrearranged human V, D and/or J gene segments, a human CH1 gene segment, a human upper hinge region gene segment, a mouse CH2 gene segment, and a mouse CH3 gene segment; producing said one or more DNA constructs; and introducing the one or more constructs into the genome of a cell. Further disclosed is a mouse cell as per the method as disclosed above or a mouse contain said cell.
Patent NZ-604997-A (NZ)
Title: Sustained release formulations using non-aqueous carriers
Inventor: HOUCHIN MARY L
IPC: A61K31/60
Filed: 2009-09-04
Abstract: The disclosure relates to a manufactured pre-mixed formulation for injection consisting essentially of a suspension of: (i) a pharmaceutically acceptable non-aqueous carrier which consists essentially of one or more triglycerides of C6-C12 fatty acids; and (ii) microspheres which consist essentially of a poly(lactide-co-glycolide) polymer having dispersed therein about 5% (w/w) exenatide as active pharmaceutical ingredient and about 2% (w/w) sucrose; wherein the ratio of lactide:glycolide in the polymer is about 1:1.
Patent NZ-616149-A (NZ)
Title: Nasal pharmaceutical formulation comprising fluticasone
Inventor: HILDEBRAND-CYRENER ANNEGRET
IPC: A61P11/02
Filed: 2012-05-24
Abstract: Provided is a nasal pharmaceutical formulation comprising fluticasone. In a preferred embodiment the formulation comprises fluticasone propionate, microcrystalline cellulose, sodium carboxymethylcellulose, disodium edetate, polysorbate 80, glycerol and one or more of benzalkonium chloride or phenylethyl alcohol, wherein the formulation is adapted to be applied as droplets and half of the droplets in the administered dose unit are between 75um and 95 um in size. The formulation may be useful for the prophylaxis or treatment of seasonal or perennial allergic and non-allergic rhinitis, and rhinoconjunctivitis.
Patent NZ-622220-A (NZ)
Title: Inhibitors of nedd8-activating enzyme
Inventor: MCCARRON ASHLEY SUE
IPC: C07D487/04
Filed: 2012-08-23
Abstract: Disclosed is the NEED8-activating enzyme (NAE) inhibitor compound { (1S,2S,4R)-4-[(6-{ [(1R,2S)-5-chloro-2-methoxy-2,3-dihydro-1H-inden-1-yl]amino} pyrimidin-4-yl)oxy]-2-hydroxycyciopentyl} methyl sulfamate and pharmaceutically acceptable salts thereof. Also disclosed are polymorphs of said NAE inhibitor compound and the use of the compound for treating cancer.
Patent NZ-622616-A (NZ)
Title: Bunded tank system
Inventor: GREEN ROBERT MICHAEL
IPC: B65D90/22
Filed: 2012-09-14
Abstract: A bunded tank system suitable for both transport and storage of bulk dangerous industrial liquids is provided. Preferably the tank system is containerised to provide efficient use of space and improved logistics for transport and storage. The containerised bunded tank system includes a plurality of bunded sub-tanks (1) arranged in an interlocking manner using corrugated walls (23) within an ISO container. In addition the container is fitted with an improved container lock.
Patent NZ-626343-A (NZ)
Title: Method for cleaning a nozzle arrangement in a spray drying apparatus, and spray drying apparatus for carrying out the method
Inventor: BERG TROELS O J P
IPC: F26B3/12
Filed: 2013-10-18
Abstract: In a spray drying apparatus, comprising in a usual manner a drying chamber, an air disperser, and at least one pressure nozzle arrangement (4), means are provided for emptying the feed in the nozzle arrangement (4) after the supply of feed from a feed system (5) is halted and before the nozzle arrangement(s) (4) are removed from the drying chamber and positioned in a cleaning system (7). The emptying takes place while maintaining atomization in the nozzle arrangement (4). The feed emptying system (6) comprises a pump (60), a pressurized air/gas source (61) and a conduit (62), and the spray drying apparatus at least one valve (45, 53, 63, 64, 65, 66) allowing switching from the feed system (5) to the feed emptying system (6).
Patent NZ-628964-A (NZ)
Title: Supercritical hydrolysis of biomass
Inventor: KAZACHKIN DMITRY VITALYEVICH
IPC: C13K13/00
Filed: 2013-07-12
Abstract: Methods are disclosed for processing biomass by single-stage supercritical hydrolysis, wherein the biomass has been size reduced. The methods comprising: size reducing a starting lignocellulosic biomass to form a lignocellulosic biomass having a particle size less than about 500 μm; forming a mixture comprising: water; and said lignocellulosic biomass having a particle size less than about 500 μm; and contacting water at a temperature of at least about 374 °C and a pressure of at least about 221 bar with said mixture for a duration sufficient to produce at least one C5 or C6 saccharide; wherein said mixture is substantially free of exogenous acid.
Patent NZ-703804-A (NZ)
Title: Dry powder formulations and methods for treating pulmonary diseases
Inventor: LIPP MICHAEL M
IPC: A61P11/10
Filed: 2011-08-26
Abstract: Disclosed are respirable dry powders comprising a respirable dry particle comprising monovalent and/or divalent metal ions, one or more therapeutic agents, and optionally an excipient. The metal ions are preferable magnesium, calcium or sodium. The powders are useful in the manufacture of a medicament for treating or preventing a respiratory disease or inflammation. The mole ratio of divalent to monovalent cation is between 2:1 and 8:1. In particular there is disclosed a composition comprising magnesium lactate, one or more therapeutic agents and leucine. The volume median geometric diameter (VMGD) is 10 microns or less, the dispersibility ratio (1/4 bar) of 2.0 or less as measured by laser diffraction (RODOS/HELOS system), and the tap density of about 0.4 g/cc to about 1.2 g/cc.